Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis

Cancer Genomics and Proteomics

Volumn 11, Issue 5, 2014, Pages 251-258

  Ilse, Peter ^a   Biesterfeld, Stefan ^a   Pomjanski, Natalia ^a   Wrobel, Christian ^a   Schramm, Martin ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

APC; Biomarker; Bronchial aspirates; Cytology; DNA methylation; Lung cancer; P16INK4A; Quantitative methylation specific PCR; RASSF1A; SHOX2

Indexed keywords

APC PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; DNA; HOMEODOMAIN PROTEIN; SHOX2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BREAST CARCINOMA; BRONCHIAL ASPIRATION PROCEDURE; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; FEMALE; FOLLOW UP; GENE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG METASTASIS; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SARCOMA; SENSITIVITY AND SPECIFICITY; SHOX2 GENE; T CELL LYMPHOMA; GENETICS; LUNG NEOPLASMS; METABOLISM; METHYLATION; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DNA METHYLATION; DNA, NEOPLASM; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; METHYLATION; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84908118666     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ferlay J, Shin HR, Bray F, Forman D., Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Kaatsch P, Spix C, Hentschel S., Katalinic A, Luttmann S, Stegmaier C., Caspritz S, Cernaj J, Ernst A, Folkerts J, Hansmann J, Kranzhöfer K, Krieghoff-Henning E, Kunz B, Penzkofer A, Treml K, Wittenberg K, Baras N, Barnes B, Bertz J, Buttermann-Schweiger N, Dahm S, Franke M, Haberland J, Kraywinkel K, Wienecke A and Wolf U: Krebs in Deutschland 2009/2010: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (eds.), Berlin 2013.
3. Goeckenjan G, Sitter H, Thomas M., Branscheid D, Flentje M, Griesinger F., Niederle N, Stuschke M, Blum T, Deppermann KM, Ficker JH, Freitag L, Lübbe AS, Reinhold T, Späth-Schwalbe E, Ukena D, Wickert M, Wolf M, Andreas S, Auberger T, Baum RP, Baysal B, Beuth J, Bickeböller H, Böcking A, Bohle RM, Bruske I, Burghuber O, Dickgreber N, Diederich S, Dienemann H, Eberhardt W, Eggeling S, Fink T, Fischer B, Franke M, Friedel G, Gauler T, Gütz S, Hautmann H, Hellmann A, Hellwig D, Herth F, Heussel CP, Hilbe W, Hoffmeyer F, Horneber M, Huber RM, Hubner J, Kauczor HU, Kirchbacher K, Kirsten D, Kraus T, Lang SM, Martens U, Mohn-Staudner A, Müller KM, Müller-Nordhorn J, Nowak D, Ochmann U, Passlick B, Petersen I, Pirker R, Pokrajac B, Reck M, Riha S, Rübe C, Schmittel A, Schönfeld N, Schütte W, Serke M, Stamatis G, Steingräber M, Steins M, Stoelben E, Swoboda L, Teschler H, Tessen HW, Weber M, Werner A, Wichmann HE, Irlinger Wimmer E, Witt C, Worth H, German Respiratory Society and German Cancer Society: Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie 65: 39-59, 2011.
4. Schreiber G and McCrory DC: Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 123: 115-128, 2003.
5. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266, 2003.
6. Grote HJ, Schmiemann V, Sarbia M and Böcking A: DNA extraction from bronchial aspirates for molecular cytology: Which method to take? Anal Cell Pathol 25: 83-88, 2003.
7. Schramm M, Wrobel C, Born I., Kazimirek M, Pomjanski N, William M., Kappes R, Gerharz CD, Biesterfeld S and Böcking A: Equivocal cytology in lung cancer diagnosis: improvement of diagnostic accuracy using adjuvant multicolor FISH, DNA image cytometry, and quantitative promoter hypermethylation analysis. Cancer Cytopathol 119: 177-192, 2011.
8. Dietrich D, Kneip C, Raji O., Liloglou T, Seegebarth A, Schlegel T., Flemming N, Rausch S, Distler J, Fleischhacker M, Schmidt B, Giles T, Walshaw M, Warburton C, Liebenberg V and Field JK: Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int J Oncol 40: 825-832, 2012.
9. Ilse P, Biesterfeld S, Pomjanski N., Fink C and Schramm M: SHOX2 DNA methylation is a tumour marker in pleural effusions. Cancer Genomics Proteomics 10: 217-223, 2013.
10. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
11. Winer J, Jung CK, Shackel I and Williams PM: Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49, 1999.
12. Steinberg DM, Fine J and Chappell R: Sample size for positive and negative predictive value in diagnostic research using case-control designs. Biostatistics 10: 94-105, 2009.
13. Robin X, Turck N, Hainard A., Tiberti N, Lisacek F, Sanchez JC and Müller M: pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12: 77, 2011.
14. Bossuyt PM, Reitsma JB, Bruns D.E., Gatsonis CA, Glasziou PP, Irwig LM, Lijmer J.G., Moher D., Rennie D and de Vet HC: Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 326: 41-44, 2003.
15. Schmidt B, Liebenberg V, Dietrich D., Schlegel T, Kneip C, Seegebarth A., Flemming N, Seemann S, Distler J, Lewin J, Tetzner R, Weickmann S, Wille U, Liloglou T, Raji O, Walshaw M, Fleischhacker M, Witt C and Field JK: SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 10: 600, 2010.
16. Kneip C, Schmidt B, Seegebarth A., Weickmann S, Fleischhacker M, Liebenberg V., Field JK and Dietrich D: SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol 6: 1632-1638, 2011.
17. Breitling LP, Yang R, Korn B., Burwinkel B and Brenner H: Tobacco smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 88: 450-457, 2011.
18. Schmiemann V, Böcking A, Kazimirek M., Onofre AS, Gabbert HE, Kappes R, Gerharz CD and Grote HJ: Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study. Clin Cancer Res 11: 7728-7734, 2005.